3.5.4.5	additional information	-	variation between 1.51 to 5.50 nmol/h/mg protein, about 100-fold lower than that in liver	695606	
3.5.4.5	0.00164	-	-	209531	
3.5.4.5	0.0059	-	-	209532	
3.5.4.5	0.011	-	-	209663	
3.5.4.5	0.536	-	activity in non-small cell lung cancer patients with CDA Lys27Lys protein, in 50 mM beta-mercaptoethanol, 0.1 M Tris-HCl, pH 8.0, substrate 0.25 mM gemcitabine	700510	
3.5.4.5	0.7254	-	activity in non-small cell lung cancer patients carrying the Lys27Gln polymorphism and the Gln27Gln polymorphism, in 50 mM beta-mercaptoethanol, 0.1 M Tris-HCl, pH 8.0, substrate 0.25 mM gemcitabine	700510	
3.5.4.5	1.68	-	crude extract, pH 7.5, at 25°C, using 2'-deoxycytidine as substrate	712889	
3.5.4.5	2.35	-	crude extract, pH 7.5, at 25°C, using cytidine as substrate	712889	
3.5.4.5	3.128	-	-	209492	
3.5.4.5	3.3	-	-	209527	
3.5.4.5	3.46	-	wild-type, substrate 2'-deoxycytidine, pH 7.5, 25°C	755377	
3.5.4.5	3.75	-	after 2.2fold purification, pH 7.5, at 25°C, using 2'-deoxycytidine as substrate	712889	
3.5.4.5	3.96	-	sarcoma tumour	209533	
3.5.4.5	4	-	amplified gene, 5'-aza-2'-deoxycytidine as substrate	209660	
3.5.4.5	4.75	-	wild-type, substrate cytidine, pH 7.5, 25°C	755377	
3.5.4.5	4.9	-	amplified gene, 2'-thiocytidine as substrate	209660	
3.5.4.5	5.44	-	after 2.3fold purification, pH 7.5, at 25°C, using cytidine as substrate	712889	
3.5.4.5	8.9	-	-	209648	
3.5.4.5	9.53	-	-	209644	
3.5.4.5	23.9	-	amplified gene, 5'-methylcytidine as substrate	209660	
3.5.4.5	29	-	colon tumour	209533	
3.5.4.5	31.8	-	amplified gene, ara-cytidine as substrate	209660	
3.5.4.5	43	-	amplified gene, cytidine as substrate	209660	
3.5.4.5	47.9	-	amplified gene, 5'-methyl-2'-deoxycytidine as substrate	209660	
3.5.4.5	64.1	-	-	209661	
3.5.4.5	68.4	-	amplified gene, 2'-fluoro-2'-deoxycytidine as substrate	209660	
3.5.4.5	74	-	-	209668	
3.5.4.5	86.7	-	pancreas tumour	209534	
3.5.4.5	90	-	-	209649	
3.5.4.5	97.6	-	amplified gene, deoxycytidine as substrate	209660	
3.5.4.5	105	-	-	209665	
3.5.4.5	118	-	-	209653	
3.5.4.5	225	-	pH 7.0, 37°C	650635	
3.5.4.5	238	-	-	209667	
3.5.4.5	570	-	-	209667	
3.5.4.5	738	-	ovarian tumour	209533	
3.5.4.5	3558	-	amplified gene	209660